AYTU vs BA · rev $66.4M vs P/E 89, rev $89.46B
Aytu BioScience Inc (AYTU) versus The Boeing Company (BA) — a side-by-side from cached financials, not a winner call.
Aytu BioScience Inc (AYTU) is a drug manufacturers - specialty & generic company listed on US.
The Boeing Company (BA) is a aerospace & defense company listed on NYSE. It is led by Kelly Ortberg.
Latest reported AYTU revenue for 2025-06-30 was $66.4M. Net income was -$13.6M. Revenue was up 1.8% from 2024-06-30 to 2025-06-30. AYTU currently screens at market cap $24.1M.
Latest reported BA revenue for 2025-12-31 was $89.46B. Net income was $2.23B. Revenue was up 34.5% from 2024-12-31 to 2025-12-31. BA currently screens at market cap $177.86B and trailing P/E 89.2.
AYTU currently screens at market cap $24.1M. BA currently screens at market cap $177.86B and trailing P/E 89.2.
Not investment advice. Open the AYTU and BA stock pages for the full models.
Not investment advice.